Latest Breaking News On - Gasthuisberg - Page 1 : comparemela.com

Nearly half of patients with giant cell arteritis achieve remission with upadacitinib

Upadacitinib Looks Promising for Patients With Giant Cell Arteritis

The phase 3 SELECT-GCA study evaluated the efficacy and safety of upadacitinib in patients 50 years of age and older with GCA.

AbbVie (ABBV) Reports Phase 3 SELECT-GCA Study of Upadacitinib Showed Positive Results in Patients With Giant Cell Arteritis

Phase 3 Upadacitinib Study Achieves Positive Results for the Treatment of Giant Cell Arteritis

Results of the SELECT-GCA study demonstrated approximately half of patients with giant cell arteritis treated with upadacitinib plus a steroid tapering regimen were able to achieve sustained remission through week 52.

Metformin Treatment Shows Benefit in Gestational Diabetes

Women randomly assigned to metformin at diagnosis had improved blood glucose levels compared with placebo and were less likely to need insulin, but questions remain.